Хирургия нейробластомы абдоминальной локализации у детей

Закрыть метаданные

Представленный литературный обзор посвящен особенностям хирургического этапа лечения нейрогенных опухолей у детей. В публикации представлены эпидемиологические данные заболевания, история формирования хирургических подходов, а также методы предоперационной визуализации и факторы риска, учитываемые при планировании оперативного вмешательства. Отдельное внимание отведено влиянию объема оперативного вмешательства при нейробластомах разных групп риска на общую и бессобытийную выживаемость в детской популяции, а также наиболее частым хирургическим осложнениям и современным подходам к их лечению.

Ключевые слова:

нейробластома

хирургия нейробластомы

Авторы:

Кривоносов А.А.

ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России

ORCID: 0000-0002-2636-0675

Миннуллин М.М.

ORCID: 0009-0002-0473-0310

Ахаладзе Д.Г.

ORCID: 0000-0002-1387-209X

Грачев Н.С.

ORCID: 0000-0002-4451-3233

Дата поступления:

25.09.2023

Дата принятия в печать:

12.10.2023

Список литературы:

Cheung N-KV, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nature Reviews Cancer. 2013;13:397-411. https://doi.org/10.1038/nrc3526
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nature Reviews Cancer. 2003;3:203-216. https://doi.org/10.1038/nrc1014
Clavel J, Lacour B, Rios P. Epidemiology. Neuroblastoma. Cham: Springer International Publishing; 2020. https://doi.org/10.1007/978-3-030-18396-7_1
Shamberger RC, Allarde-Segundo A, Kozakewich HP, Grier HE. Surgical management of stage III and IV neuroblastoma: resection before or after chemotherapy? Journal of Pediatric Surgery. 1991;26:1113-1117; discussion 1117—1118. https://doi.org/10.1016/0022-3468(91)90685-m
Koop CE, Kiesewetter WB, Horn RC. Neuroblastoma in childhood; survival after major surgical insult to the tumor. Surgery. 1955;38:272-278.
Harrison J, Myers M, Rowen M, Vermund H. Results of combination chemotherapy, surgery, and radiotherapy in children with neuroblastoma. Cancer. 1974;34:485-490. https://doi.org/10.1002/1097-0142(197409)34:3<485::aid-cncr2820340302>3.0.co;2-8
Hollmann G, Lampert F. [Carcinochemotherapy in pediatric surgery (author’s transl)]. Langenbeck’s Archives of Surgery. 1975;339:95-98. https://doi.org/10.1007/BF01257495
Tsunooka H. Progress in diagnostic methods in pediatric surgery. Geka Chiryo. 1972;26:140-160.
Nitschke R, Smith EI, Shochat S, Altshuler G, Travers H, Shuster JJ, Hayes FA, Patterson R, McWilliams N. Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study. Journal of Clinical Oncology. 1988;6(8):1271-1279. https://doi.org/10.1200/JCO.1988.6.8.1271
Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Journal of Clinical Oncology. 1993;11(8):1466-1477. https://doi.org/10.1200/JCO.1993.11.8.1466
Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. Journal of Clinical Oncology. 2009;27(2):289-297. https://doi.org/10.1200/JCO.2008.16.6785
Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD; INRG Task Force. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. Journal of Clinical Oncology. 2009;27(2):298-303. https://doi.org/10.1200/JCO.2008.16.6876
Monclair T, Mosseri V, Cecchetto G, De Bernardi B, Michon J, Holmes K. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group. Pediatric Blood & Cancer. 2015;62:1536-1542. https://doi.org/10.1002/pbc.25460
Keene DJ, Minford J, Craigie RJ, Humphrey G, Bruce J. Laparostomy closure in stage 4S neuroblastoma. Journal of Pediatric Surgery. 2011;46:e1-4. https://doi.org/10.1016/j.jpedsurg.2010.08.064
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery. 2004;240:205-213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Annals of Surgery. 2009;250(2):187-196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. Journal of the National Cancer Institute. 1984;73:405-416. https://doi.org/10.1093/jnci/73.2.405
Gupta A, Kumar A, Walters S, Chait P, Irwin MS, Gerstle JT. Analysis of needle versus open biopsy for the diagnosis of advanced stage pediatric neuroblastoma. Pediatric Blood & Cancer. 2006;47:875-879. https://doi.org/10.1002/pbc.20666
Ray-Coquard I, Ranchère-Vince D, Thiesse P, Ghesquières H, Biron P, Sunyach MP, Rivoire M, Lancry L, Méeus P, Sebban C, Blay JY. Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses. European Journal of Cancer. 2003;39(14):2021-2025. https://doi.org/10.1016/s0959-8049(03)00430-1
Hussain HK, Kingston JE, Domizio P, Norton AJ, Reznek RH. Imaging-guided core biopsy for the diagnosis of malignant tumors in pediatric patients. American Journal of Roentgenology. 2001;176:43-47. https://doi.org/10.2214/ajr.176.1.1760043
Iwanaka T, Kawashima H, Uchida H. The laparoscopic approach of neuroblastoma. Seminars in Pediatric Surgery. 2007;16:259-265. https://doi.org/10.1053/j.sempedsurg.2007.06.008
Torriani M, Etchebehere M, Amstalden E. Sonographically guided core needle biopsy of bone and soft tissue tumors. Journal of Ultrasound in Medicine. 2002;21:275-281. https://doi.org/10.7863/jum.2002.21.3.275
Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES. Needle core vs open biopsy for diagnosis of intermediate- and high-risk neuroblastoma in children. Journal of Pediatric Surgery. 2012;47(6):1261-1266. https://doi.org/10.1016/j.jpedsurg.2012.03.040
Paraboschi I, Bolognesi E, Giannettoni A, Avanzini S, Torre M, Martucciello G. The Role of Biopsy in the Workup of Patients with Neuroblastoma: Comparison of the Incidence of Surgical Complications and the Diagnostic Reliability of Diverse Techniques. Children. 2021;8. https://doi.org/10.3390/children8060500
Mullassery D, Sharma V, Salim A, Jawaid WB, Pizer BL, Abernethy LJ, Losty PD. Open versus needle biopsy in diagnosing neuroblastoma. Journal of Pediatric Surgery. 2014;49(10):1505-1507. https://doi.org/10.1016/j.jpedsurg.2014.05.015
Терновая Е.С., Качанов Д.Ю., Шаманская Т.В., Щербаков А.П., Варфоломеева С.Р., Рубцова Н.А., Терещенко Г.В. Факторы риска по данным визуализации у пациентов с нейробластомой. Обзор литературы. Российский журнал детской гематологии и онкологии (РЖДГиО). 2019;6:31-43. https://doi.org/10.21682/2311-1267-2019-6-3-31-43
Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, Giammarile F, Schmidt M, Shulkin BL, Matthay KK, Lewington VJ, Sarnacki S, Hero B, Kaneko M, London WB, Pearson AD, Cohn SL, Monclair T; International Neuroblastoma Risk Group Project. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261:243-257. https://doi.org/10.1148/radiol.11101352
Lanza C, Galeazzi V, Carboni N, De Berardinis A, De Marino L, Barile A, Giovagnoni A. Neuroblastoma image-defined risk factors in adrenal neuroblastoma: role of radiologist. Gland Surgery. 2019;8(suppl 3):S168-S177. https://doi.org/10.21037/gs.2019.06.01
Lim II, Goldman DA, Farber BA, Murphy JM, Abramson SJ, Basu E, Roberts S, LaQuaglia MP, Price AP. Image-defined risk factors for nephrectomy in patients undergoing neuroblastoma resection. Journal of Pediatric Surgery. 2016;51(6):975-980. https://doi.org/10.1016/j.jpedsurg.2016.02.069
Yoneda A, Nishikawa M, Uehara S, Oue T, Usui N, Inoue M, Fukuzawa M, Okuyama H. Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma? European Journal of Pediatric Surgery. 2016;26:117-122. https://doi.org/10.1055/s-0035-1566100
Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high-risk neuroblastoma: a Children’s Cancer Group study. Journal of Pediatric Surgery. 2004;39:931-936. https://doi.org/10.1016/j.jpedsurg.2004.02.041
La Quaglia MP, Kushner BH, Su W, Heller G, Kramer K, Abramson S, Rosen N, Wolden S, Cheung NK. The impact of gross total resection on local control and survival in high-risk neuroblastoma. Journal of Pediatric Surgery. 2004;39(3):412-417; discussion 412-417. https://doi.org/10.1016/j.jpedsurg.2003.11.028
La Quaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsley KL, Cheung NK. Stage 4 neuroblastoma diagnosed at more than 1 year of age: Gross total resection and clinical outcome. Journal of Pediatric Surgery. 1994;29(8):1162-1165; discussion 1165-1166. https://doi.org/10.1016/0022-3468(94)90301-8
Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17(1):520. https://doi.org/10.1186/s12885-017-3493-0
Fischer J, Pohl A, Volland R, Hero B, Dübbers M, Cernaianu G, Berthold F, von Schweinitz D, Simon T. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months. BMC Cancer. 2017;17:520. https://doi.org/10.1186/s12885-017-3493-0
Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. Journal of Clinical Oncology. 2013;31:752-758. https://doi.org/10.1200/JCO.2012.45.9339
von Allmen D, Davidoff AM, London WB, Van Ryn C, Haas-Kogan DA, Kreissman SG, Khanna G, Rosen N, Park JR, La Quaglia MP. Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. Journal of Clinical Oncology. 2017;35(2):208-216. https://doi.org/10.1200/JCO.2016.67.2642
Emre Ş, Özcan R, Bakır AC, Kuruğoğlu S, Çomunoğlu N, Şen HS, Celkan T, Tekant GT. Adrenal masses in children: Imaging, surgical treatment and outcome. Asian Journal of Surgery. 2020;43(1):207-212. https://doi.org/10.1016/j.asjsur.2019.03.012
Phelps HM, Lovvorn HN 3rd. Minimally Invasive Surgery in Pediatric Surgical Oncology. Children. 2018;5. https://doi.org/10.3390/children5120158
Irtan S, Brisse HJ, Minard-Colin V, Schleiermacher G, Canale S, Sarnacki S. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors. Pediatric Blood & Cancer. 2015;62:257-261. https://doi.org/10.1002/pbc.25248
Gurria JP, Malek MM, Heaton TE, Gehred A, Lautz TB, Rhee DS, Tracy ET, Grant CN, Baertshiger RM, Bruny J, Christison-Lagay ER, Rodeberg DA, Ehrlich PF, Dasgupta R, Aldrink JH. Minimally invasive surgery for abdominal and thoracic neuroblastic tumors: A systematic review by the APSA Cancer committee. Journal of Pediatric Surgery. 2020;55(11):2260-2272. https://doi.org/10.1016/j.jpedsurg.2020.02.019
Gabra HO, Irtan S, Cross K, Lobos P, Froeba-Pohl A, Pio L, Virgone C, Guillén Burrieza G, Gómez Chacón Villalba J, Riccipetitoni G, Guérin F, Nightingale M, Heloury Y, Faraj S, Leclair M, Scalabre A, Mattioli G, Warmann SW, Fuchs J, Basta N, Bjørnland K, Matthyssens LE, Losty PD, Sarnacki S. Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines. European Journal of Surgical Oncology. 2022;48(1):283-291. https://doi.org/10.1016/j.ejso.2021.08.013
Cecchetto G, Mosseri V, De Bernardi B, Helardot P, Monclair T, Costa E, Horcher E, Neuenschwander S, Tomà P, Rizzo A, Michon J, Holmes K. Surgical Risk Factors in Primary Surgery for Localized Neuroblastoma: The LNESG1 Study of the European International Society of Pediatric Oncology Neuroblastoma Group. Journal of Clinical Oncology. 2005;23(33):8483-8489. https://doi.org/10.1200/jco.2005.02.4661
Simon T, Hero B, Benz-Bohm G, von Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial. Pediatric Blood & Cancer. 2008;50:965-969. https://doi.org/10.1002/pbc.21343
Shamberger RC, Smith EI, Joshi VV, Rao PV, Hayes FA, Bowman LC, Castleberry RP. The risk of nephrectomy during local control in abdominal neuroblastoma. Journal of Pediatric Surgery. 1998;33(2):161-164. https://doi.org/10.1016/s0022-3468(98)90424-9
Günther P, Tröger J, Holland-Cunz S, Behnisch W, Hinz U, Romero P, Schenk JP. Surgical Complications in Abdominal Tumor Surgery in Children. Experiences at a Single Oncological Center. European Journal of Pediatric Surgery. 200919(5):297-303. https://doi.org/10.1055/s-0029-1220681
Cañete A, Jovani C, Lopez A, Costa E, Segarra V, Fernández JM, Verdeguer A, Velázquez J, Castel V. Surgical treatment for neuroblastoma: Complications during 15 years’ experience. Journal of Pediatric Surgery. 1998;33(10):1526-1530. https://doi.org/10.1016/s0022-3468(98)90490-0
Froeba-Pohl A, Muehling J, Vill K, Grote V, Komm T, Seitz D, Kappler R, von Schweinitz D. Lymphatic Leakage after Surgery for Neuroblastoma: A Rare Complication? Eur Journal of Pediatric Surgery. 2021;31(2):140-146. https://doi.org/10.1055/s-0039-1701008
La Quaglia MP. Surgical management of neuroblastoma. Seminars in Pediatric Surgery. 2001;10:132-139. https://doi.org/10.1053/spsu.2001.24889
von Schweinitz D, Hero B, Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma. European Journal of Pediatric Surgery. 2002;12:402-409. https://doi.org/10.1055/s-2002-36952
Moon S-B, Park K-W, Jung S-E, Youn W-J. Neuroblastoma: treatment outcome after incomplete resection of primary tumors. Pediatric Surgery International. 2009;25:789-793. https://doi.org/10.1007/s00383-009-2417-8
Günther P, Holland-Cunz S, Schupp CJ, Stockklausner C, Hinz U, Schenk J-P. Significance of Image-defined Risk Factors for Surgical Complications in Patients with Abdominal Neuroblastoma. European Journal of Pediatric Surgery. 2011;21:314-317. https://doi.org/10.1055/s-0031-1280824
Holmes K, Pötschger U, Pearson ADJ, Sarnacki S, Cecchetto G, Gomez-Chacon J, Squire R, Freud E, Bysiek A, Matthyssens LE, Metzelder M, Monclair T, Stenman J, Rygl M, Rasmussen L, Joseph JM, Irtan S, Avanzini S, Godzinski J, Björnland K, Elliott M, Luksch R, Castel V, Ash S, Balwierz W, Laureys G, Ruud E, Papadakis V, Malis J, Owens C, Schroeder H, Beck-Popovic M, Trahair T, Forjaz de Lacerda A, Ambros PF, Gaze MN, McHugh K, Valteau-Couanet D, Ladenstein RL; International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN). Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study. Journal of Clinical Oncology. 2020;38(25):2902-2915. https://doi.org/10.1200/JCO.19.03117
Tsuchida Y, Yokoyama J, Kaneko M, Uchino J, Iwafuchi M, Makino S, Matsuyama S, Takahashi H, Okabe I, Hashizume K, et al. Therapeutic significance of surgery in advanced neuroblastoma: a report from the study group of Japan. Journal of Pediatric Surgery. 1992;27(5):616-622. https://doi.org/10.1016/0022-3468(92)90461-f
Lv S, Wang Q, Zhao W, Han L, Wang Q, Batchu N, Ulain Q, Zou J, Sun C, Du J, Song Q, Li Q. A review of the postoperative lymphatic leakage. Oncotarget. 2017;8(40):69062-69075. https://doi.org/10.18632/oncotarget.17297
Kim EA, Park H, Jeong SG, Lee C, Lee JM, Park CT. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma. Journal of Obstetrics and Gynaecology Research. 2014;40:622-626. https://doi.org/10.1111/jog.12183
Zeidan S, Delarue A, Rome A, Roquelaure B. Fibrin glue application in the management of refractory chylous ascites in children. Journal of Pediatric Gastroenterology and Nutrition. 2008;46:478-481. https://doi.org/10.1097/MPG.0b013e31815ce5be
Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. Journal of Vascular and Interventional Radiology. 1998;9:727-734. https://doi.org/10.1016/s1051-0443(98)70382-3

Закрыть метаданные